Tag: Therapeutics Goods Administration
Australia to purchase 51 million doses of COVID-19 vaccine from Novavax
American vaccine development company Novavax, Inc. has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, its...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
